Relationship between left ventricular mass and carotid intima media thickness in obese adolescents with non-alcoholic fatty liver disease

Journal of Pediatric Endocrinology and Metabolism

Volumn 25, Issue 9-10, 2012, Pages 927-934

  Sert, Ahmet ^a   Pirgon, Ozgur ^b   Aypar, Ebru ^a   Yilmaz, Hakan ^a   Odabas, Dursun ^a  

^a KONYA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b SULEYMAN DEMIREL UNIVERSITY   (Turkey)

Author keywords

Adolescent; Carotid intima media thickness; Insulin resistance; Left ventricular mass; Non alcoholic fatty liver disease

Indexed keywords

AMINOTRANSFERASE; GLUCOSE; INSULIN;

ADOLESCENT; ADOLESCENT DISEASE; AMINOTRANSFERASE BLOOD LEVEL; ARTERIAL WALL THICKNESS; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR RISK; CHILD; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET RESTRICTION; ECHOCARDIOGRAPHY; FEMALE; GLUCOSE BLOOD LEVEL; HEART LEFT VENTRICLE MASS; HOMEOSTASIS; HUMAN; HUMAN TISSUE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; OBESITY; SCHOOL CHILD;

ADOLESCENT; CAROTID INTIMA-MEDIA THICKNESS; CHILD; FATTY LIVER; FEMALE; HEART VENTRICLES; HUMANS; INSULIN RESISTANCE; MALE; OBESITY;

EID: 84867830463     PISSN: 0334018X     EISSN: 21910251     Source Type: Journal    
DOI: 10.1515/jpem-2012-0187     Document Type: Article

References (36)

1. Manco M, Bottazzo G, DeVito R, Marcellini M, Mingrone G, et al. Nonalcoholic fatty liver disease in children. J Am Coll Nutr 2008;27:667-76.
2. Targher G, Day CP, Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 2010;363:1341-50.
3. Litwin M, Niemirska A. Intima-media thickness measurements in children with cardiovascular risk factors. Pediatr Nephrol 2009;24:707-19.
4. Sookoian S, Pirola CJ. Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a systematic review. J Hepatol 2008;49:600-17.
5. Pacifico L, Cantisani V, Ricci P, Osborn JF, Schiavo E, et al. Nonalcoholic fatty liver disease and carotid atherosclerosis in children. Pediatr Res 2008;63:423-7.
6. Demircioǧlu F, Koçyiǧit A, Arslan N, Cakmakç i H, Hizli S, et al. Intima-media thickness of carotid artery and susceptibility to atherosclerosis in obese children with nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr 2008;47:68-75.
7. Li X, Li S, Ulusoy E, Chen W, Srinivasan SR, et al. Childhood adiposity as a predictor of cardiac mass in adulthood: the Bogalusa Heart Study. Circulation 2004;110:3488-92.
8. Bluemke DA, Kronmal RA, Lima JA, Liu K, Olson J, et al. The relationship of left ventricular mass and geometry to incident cardiovascular events: the MESA (Multi-Ethnic Study of Atherosclerosis) Study. J Am Coll Cardiol 2008;52:2148-55.
9. Ganau A, Saba PS, Roman MJ, de Simone G, Realdi G, et al. Ageing induces left ventricular concentric remodelling in normotensive subjects. J Hypertens 1995;13:1818-22.
10. Markus MR, Stritzke J, Lieb W, Mayer B, Luchner A, et al. Implications of persistent prehypertension for ageing-related changes in left ventricular geometry and function: the MONICA/ KORA Augsburg study. J Hypertens 2008;26:2040-49.
11. Ozturk A, Mazicioglu MM, Hatipoglu N, Budak N, Keskin G, et al. Reference body mass index curves for Turkish children 6 to 18 years of age. J Pediatr Endocrinol Metab 2008;21:827-36.
12. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in men. Diabetologia 1985;28:412-29.
13. Keskin M, Kurtoglu S, Kendirci M, Atabek ME, Yazici C. Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics 2005;115:500-3.
14. Tominaga K, Kurata JH, Chen YK, Fujimoto E, Miyagawa S, et al. Prevalence of fatty liver in Japanese children and relationship to obesity. An epidemiological ultrasonographic survey. Dig Dis Sci 1995;40:2002 - 9.
15. Stephen CH, Tri HL, Stacey M.A. Non-alcoholic steatohepatitis. In: Schiff ER, Sorrell MF, Maddrey WC, editors. Schiff ' s diseases of the liver, 9th ed. Philadephia: Lippincott Williams & Wilkins, 2002:1261-89.
16. Alisi A, Manco M, Vania A, Nobili V. Pediatric nonalcoholic fatty liver disease in 2009. J Pediatr 2009;155:469-74.
17. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986;57:450-8.
18. Simon A, Megnien JL, Chironi G. The value of carotid intima-media thickness for predicting cardiovascular risk. Arterioscler Thromb Vasc Biol 2010;30:182-5.
19. Fracanzani AL, Burdick L, Raselli S, Pedotti P, Grigore L, et al. Carotid artery intima-media thickness in nonalcoholic fatty liver disease. Am J Med 2008;121:72-8.
20. T argher G, Bertolini L, Padovani R. Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease. Diabetes Care 2006;29:1325-30.
21. Caserta CA, Pendino GM, Amante A, Vacalebre C, Fiorillo MT, et al. Cardiovascular risk factors, nonalcoholic fatty liver disease, and carotid artery intima-media thickness in an adolescent population in southern Italy. Am J Epidemiol 2010;171:1195-202.
22. Daniels S.R. Obesity in the pediatric patient: cardiovascular complications. Prog Pediatr Cardiol 2001;12:161-7.
23. McGill Jr HC, McMahan CA, Herderick EE, Tracy RE, Malcom GT, et al. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Obesity accelerates the progression of coronary atherosclerosis in young men. Circulation 2002;105:2712-8.
24. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined ventricular mass in the Framingham Heart Study. N Engl J Med 1990;322:1561-6.
25. Urbina EM, Gidding SS, Bao W, Pickoff AS, Berdusis K, et al. Effect of body size, ponderosity, and blood pressure on left ventricular growth in children and young adults in the Bogalusa Heart Study. Circulation 1995;91:2400-6.
26. Chinali M, de Simone G, Roman MJ, Lee ET, Best GL, et al. Impact of obesity on cardiac geometry and function in a population of adolescents. The Strong Heart Study. J Am Coll Cardiol 2006;47:2267-73.
27. Mantovani A, Zoppini G, Targher G, Golia G, Bonora E. Non-alcoholic fatty liver disease is independently associated with left ventricular hypertrophy in hypertensive type 2 diabetic individuals. J Endocrinol Invest 2012;35:215-8.
28. Bonapace S, Perseghin G, Molon G, Canali G, Bertolini L, et al. Nonalcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in patients with type 2 diabetes. Diabetes Care 2012;35:389-95.
29. Iacobellis G, Ribaudo MC, Zappaterreno A, Vecci E, Tiberti C, et al. Relationship of insulin sensitivity and left ventricular mass in uncomplicated obesity. Obes Res 2003;11:518-24.
30. Fotbolcu H, Yakar T, Duman D, Karaahmet T, Tigen K, et al. Impairment of the left ventricular systolic and diastolic function in patients with non-alcoholic fatty liver disease. Cardiol J 2010;17:457-63.
31. Selberg O, Burchert W, vd Hoff J, Meyer GJ, Hundeshagen H, et al. Insulin resistance in liver cirrhosis. Positron-emission tomography scan analysis of skeletal muscle glucose metabolism. J Clin Invest 1993;91:1897 - 902.
32. Imano E, Kanda T, Nakatani Y, Motomura M, Arai K, et al. Impaired splanchnic and peripheral glucose uptake in liver cirrhosis. J Hepatol 1999;31:469-73.
33. Chan DF, Li AM, Chu WC, Chan MH, Wong EM, et al. Hepatic steatosis in obese Chinese children. Int J Obes Relat Metab Disord 2004;28:1257-63.
34. Alikasifoglu A, Gonc N, Ozon ZA, Sen Y, Kandemir N. The relationship between serum adiponectin, tumor necrosis factor-alpha, leptin levels and insulin sensitivity in childhood and adolescent obesity: adiponectin is a marker of metabolic syndrome. J Clin Res Pediatr Endocrinol 2009;1:233-9.
35. Rosa JS, Heydari S, Oliver SR, Flores RL, Pontello AM, et al. Inflammatory cytokine profiles during exercise in obese, diabetic, and healthy children. J Clin Res Pediatr Endocrinol 2011;3:115-21.
36. Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, et al. Nonalcoholic fatty liver, steato-hepatitis, and the metabolic syndrome. Hepatology 2003;37:917-23.